Bloomberg Intelligence: Walmart Tumbles on US Sales (Podcast)

Walmart reported US store sales (excluding fuel) rose just 2.6% YoY in Q2—its slowest US growth in six years—yet it still raised full-year guidance for sales and adjusted operating income, alongside continued e-commerce growth. Deere shares rose as it flagged improving machinery orders and raised the lower end of its annual profit forecast. Separately, Meta is increasing spend on AI model access via Microsoft Azure while also facing a bipartisan states lawsuit alleging deceptive design to drive compulsive use among young users.

Analysis

WMT’s read-through is less about one soft quarter and more about a pressure test on the lower-income consumer: smaller basket sizes usually mean either deflation, trade-down, or both, and that tends to push more share toward the cheapest national chain while compressing margins at grocers, dollar stores, and mid-tier discretionary retailers. The market may overreact on the comp miss because the company still has the pricing power to defend traffic; the real tell over the next 1-3 months is whether gross margin holds as it leans into price cuts. If margins start to slip faster than sales improve, the defensive premium starts to look expensive.

DE looks like a cleaner cyclical inflection: the important signal is not one order print, but that used-equipment inventory and replacement demand may be normalizing together. That would be a favorable setup for ag dealers and premium machinery names, with the biggest second-order winners likely CNHI and AGCO if the recovery broadens beyond Deere’s installed base. The risk is that this is just order pull-forward; a grain price rollover or tighter farm credit would reverse the thesis within 1-2 quarters.

META’s AI model spend is economically meaningful mainly as a reminder that frontier AI is becoming a variable operating expense, which should help MSFT’s Azure monetization narrative more than it hurts META’s P&L near term. The lawsuit is the more durable risk: remedies that constrain product design or ad targeting would matter over 6-18 months, not days. Contrarian take: the market may be overpricing the regulatory headline while underpricing how little incremental Azure spend can move MSFT’s valuation absent broader enterprise AI adoption.

Key Decisions for Investors

• Long MSFT / short META for 1-3 months: MSFT captures external AI workload spend and has lower regulatory uncertainty; cover if META breaks higher on no follow-through from the lawsuit or if Azure disclosure is immaterial in upcoming cloud prints.
• Buy DE on pullbacks or add vs CNHI/AGCO in a relative-value pair for 1-2 quarters: the risk/reward favors a cyclical re-rating if farm orders keep stabilizing; invalidated if grain prices weaken or Deere guides down on used-equipment deterioration.
• Use WMT as a consumer barometer, not an outright short: if price cuts continue and gross margin stays intact, go long WMT / short XRT on weakness for 1-2 months; stop if comps re-accelerate broadly and the trade-down thesis fades.
• Avoid chasing META downside on the lawsuit alone; if shares sell off hard, consider taking profits on any short exposure unless there is evidence of ad-targeting or product-remedy risk in court filings.